Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-4,264
Closed -$492K 543
2023
Q2
$492K Buy
+4,264
New +$484K 0.02% 648
2022
Q4
Sell
-11,327
Closed -$975K 1721
2022
Q3
$975K Buy
+11,327
New +$1.01M 0.03% 494
2021
Q3
Sell
-514,388
Closed -$40M 1514
2021
Q2
$40M Buy
+514,388
New +$38.3M 0.92% 11
2021
Q1
Sell
-427,259
Closed -$33.3M 965
2020
Q4
$33.3M Buy
+427,259
New +$32.7M 1.11% 14

Other funds holding MRK

Ergoteles's MRK Position: Q3 2023 in Review

Ergoteles sold out of Merck (MRK) in Q3 2023, closing a stake of 4,264 shares — an estimated $492K sold.

Ergoteles first reported a position in MRK in Q4 2020 and held it in 4 quarters. The position peaked at $40M in Q2 2021. 3,213 funds tracked by Wall St. Rank hold MRK as of Q3 2023.

  • Ergoteles reported no remaining Merck position as of Q3 2023 after selling out during the quarter.
  • Ergoteles sold 4,264 Merck shares in Q3 2023, an estimated $492K.
  • Ergoteles first reported a position in Merck in Q4 2020 and held it in 4 quarters.
  • Ergoteles's Merck position peaked at $40M in Q2 2021.
  • 3,213 funds tracked by Wall St. Rank held Merck as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.